Adamas Pharmaceuticals/ US00548A1060 /
- - | Diff. - | Volumen | Geld- | Brief- | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
-USD | - | - Umsatz: - |
-Geld Vol: - | -Brief Vol: - | - | - |
GlobeNewswire
13:00
Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...
GlobeNewswire
11:42
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to...
GlobeNewswire
11:41
SQSP (NYSE) REMINDER: BFA Law Reminds Squarespace Shareholders to Inquire About Ongoing Investigatio...
GlobeNewswire
11:39
SPT (NYSE) FRAUD ALERT: Sprout Social, Inc. Investors who Lost Money when Stock Plummeted 40% are En...
GlobeNewswire
11:37
PATH (NYSE) INVESTOR ALERT: UiPath, Inc. Investigated for Securities Fraud After 34% Stock Drop, Con...
GlobeNewswire
11:36
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation ...
GlobeNewswire
11:34
CAE (NYSE) INVESTOR ALERT: CAE, Inc. Investigated for Securities Fraud from Impairment Charges, Cont...
GlobeNewswire
11:33
BIIB (NASDAQ) FRAUD ALERT: Biogen Inc. Investors who Lost Money are Encouraged to Contact BFA Law ab...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite